1. Academic Validation
  2. Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer

Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer

  • Structure. 2019 Jan 2;27(1):125-133.e4. doi: 10.1016/j.str.2018.10.025.
Ping Wu 1 Christopher J Sneeringer 2 Keith E Pitts 2 Eric S Day 3 Bryan K Chan 4 Binqing Wei 4 Isabelle Lehoux 5 Kyle Mortara 5 Hong Li 6 Jiansheng Wu 6 Yvonne Franke 5 John G Moffat 2 Jane L Grogan 7 Timothy P Heffron 4 Weiru Wang 8
Affiliations

Affiliations

  • 1 Department of Structural Biology, Genentech, South San Francisco, CA 94080, USA.
  • 2 Department of Biochemical Pharmacology, Genentech, South San Francisco, CA 94080, USA.
  • 3 Department of Late Stage Pharmaceutical Development, Genentech, South San Francisco, CA 94080, USA.
  • 4 Department of Discovery Chemistry, Genentech, South San Francisco, CA 94080, USA.
  • 5 Department of Biomolecular Resources, Genentech, South San Francisco, CA 94080, USA.
  • 6 Department of Protein Chemistry, Genentech, South San Francisco, CA 94080, USA.
  • 7 Department of Cancer Immunology, Genentech, South San Francisco, CA 94080, USA.
  • 8 Department of Structural Biology, Genentech, South San Francisco, CA 94080, USA. Electronic address: [email protected].
Abstract

Enhancement of antigen-specific T cell immunity has shown significant therapeutic benefit in infectious diseases and Cancer. Hematopoietic progenitor kinase-1 (HPK1) is a negative-feedback regulator of T cell receptor signaling, which dampens T cell proliferation and effector function. A recent report showed that a catalytic dead mutant of HPK1 phenocopies augmented T cell responses observed in HPK1-knockout mice, indicating that kinase activity is critical for function. We evaluated active and inactive mutants and determined crystal structures of HPK1 kinase domain (HPK1-KD) in apo and ligand bound forms. In all structures HPK1-KD displays a rare domain-swapped dimer, in which the activation segment comprises a well-conserved dimer interface. Biophysical measurements show formation of dimer in solution. The activation segment adopts an α-helical structure which exhibits distinct orientations in active and inactive states. This face-to-face configuration suggests that the domain-swapped dimer may possess alternative selectivity for certain substrates of HPK1 under relevant cellular context.

Keywords

HPK1; X-ray crystallography; cancer; immunology; inhibitor; kinase.

Figures
Products